This week, Kenvue, the consumer health spin-off from Johnson & Johnson, found itself at the epicenter of a market tempest this week. It began when The Wall Street Journal reported Robert F. Kennedy Jr., a longtime promoter of scientifically baseless causes for autism, planned to link Tylenol use during pregnancy to the condition. A stock rout ensued, since Kennedy is …
Read More »Tylenol maker’s stock lost billions after a rumor linking the medicine to autism. Wall Street says buy the dip as one bank sees a ‘major overreaction’
